These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6090359)
21. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor. Zaghloul MS; Dorie MJ; Kallman RF Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):417-25. PubMed ID: 8514539 [TBL] [Abstract][Full Text] [Related]
22. Sensitizers and radiation dose fractionation: results and interpretations. Hill RP Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1049-54. PubMed ID: 2943705 [TBL] [Abstract][Full Text] [Related]
23. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation. Teicher BA; Herman TS; Hopkins RE; Menon K Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):969-74. PubMed ID: 1917627 [TBL] [Abstract][Full Text] [Related]
24. Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells. Wondergem J; Haveman J; van der Schueren E; van den Hoeven H; Breur K Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1323-31. PubMed ID: 7141911 [TBL] [Abstract][Full Text] [Related]
25. Sensitizers and protectors in radiotherapy. Brown JM Cancer; 1985 May; 55(9 Suppl):2222-8. PubMed ID: 2983876 [TBL] [Abstract][Full Text] [Related]
26. Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice. Kanclerz A; Chapman JD Int J Radiat Oncol Biol Phys; 1988 Feb; 14(2):309-16. PubMed ID: 2828290 [TBL] [Abstract][Full Text] [Related]
27. [Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue]. Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G Radiobiol Radiother (Berl); 1983; 24(5):597-614. PubMed ID: 6316407 [No Abstract] [Full Text] [Related]
28. Impact of stromal sensitivity on radiation response of tumors. Budach W; Taghian A; Freeman J; Gioioso D; Suit HD J Natl Cancer Inst; 1993 Jun; 85(12):988-93. PubMed ID: 8496984 [TBL] [Abstract][Full Text] [Related]
29. 5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice. Greer S; Santos O; Gottlieb C; Schwade J; Marion HS Int J Radiat Oncol Biol Phys; 1992; 22(3):505-10. PubMed ID: 1735688 [TBL] [Abstract][Full Text] [Related]
30. Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy. Teicher BA; Herman TS; Jones SM Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):945-51. PubMed ID: 2211263 [TBL] [Abstract][Full Text] [Related]
31. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells. Curtis SB; Tenforde TS; Afzal SM Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1203-5. PubMed ID: 6432747 [TBL] [Abstract][Full Text] [Related]
32. Tumor radiosensitization with concomitant bone marrow radioprotection: a study in mice using diethyldithiocarbamate (DDC) under oxygenated and hypoxic conditions. Evans RG Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1163-9. PubMed ID: 2987165 [TBL] [Abstract][Full Text] [Related]
33. Radiosensitization of two murine fibrosarcomas with 6-thioguanine. Kim JH; Alfieri AA; Kim SH; Hong SS Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):583-6. PubMed ID: 2318691 [TBL] [Abstract][Full Text] [Related]
34. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range. Grdina DJ; Thames HD; Milas L Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):379-83. PubMed ID: 6706731 [TBL] [Abstract][Full Text] [Related]
35. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Sun JR; Brown JM Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067 [TBL] [Abstract][Full Text] [Related]
36. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy. Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145 [No Abstract] [Full Text] [Related]
37. Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSaII murine fibrosarcomas. Okunieff P; Suit HD J Natl Cancer Inst; 1987 Aug; 79(2):377-81. PubMed ID: 3474467 [TBL] [Abstract][Full Text] [Related]
38. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations. Grdina DJ; Sigdestad CP; Jovonovich JA Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138 [TBL] [Abstract][Full Text] [Related]
39. [The modification of radiation effect by nucleoside related compounds on a murine tumor given with local radiotherapy and on survival following whole body irradiation]. Sougawa M; Tanaka Y Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Oct; 49(10):1298-303. PubMed ID: 2616263 [TBL] [Abstract][Full Text] [Related]